Clinical Trial Update: 68Ga-DOTA-NI-FAPI04 PET/CT in Patients With Various Types of Cancer [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial update for 68Ga-DOTA-NI-FAPI04 PET/CT imaging in patients with various cancers; the study is currently recruiting. Sponsor is the First Affili…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• 68Ga-DOTA-NI-FAPI04 (68Ga-DOTA-NI-FAPI04)

Snippet

Sponsor: First Affiliated Hospital of Fujian Medical University | Conditions: Tumor | EARLY_Phase 1 | Status: RECRUITING